Colgate-Palmolive (CL) Tops Q2 EPS by 4c

Colgate-Palmolive (NYSE: CL) reported Q2 EPS of $0.91, $0.04 better than the analyst estimate of $0.87. Revenue for the quarter came in at $5.06 billion versus the consensus estimate of $5.01 billion.

• Full Year 2024 Guidance:

Based on current spot rates:

• The Company still expects net sales growth of 2% to 5% including a mid-single-digit negative impact from foreign exchange.
• The Company is raising its organic sales growth guidance to 6% to 8% (versus 5% to 7% previously).
• On a GAAP basis, the Company still expects gross profit margin expansion, increased advertising investment and double-digit earnings per share growth.
• On a non-GAAP (Base Business) basis, the Company still expects gross profit margin expansion and increased advertising investment and increased its earnings per share growth guidance to 8% to 11% (versus mid to high-single-digit previously).

For earnings history and earnings-related data on Colgate-Palmolive (CL) click here.

You May Also Be Interested In

• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• Deutsche Bank Downgrades Spire Healthcare (SPI:LN) (SRRHF) to Hold
• ICICI Bank (ICICIBC:IN) (IBN) PT Raised to INR2,000 at Goldman Sachs